Clinical Trial Update: Ketotifen as a Treatment for Vascular Leakage During Dengue Fever [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating ketotifen to reduce vascular leakage in dengue fever. The trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Fever
• Pleural Effusion

Drugs mentioned

• Ketotifen (Ketotifen)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Dengue Fever, Pleural Effusion | Phase 4 | Status: UNKNOWN